Tomomaro Etoh

A change in promoter methylation of hMLH1 is a cause of acquired resistance to platinum-based chemotherapy in epithelial ovarian cancer.

Yoh Watanabe, Haruhiko Ueda, Tomomaro Etoh et al. · PubMed · 2007 · 49 citations

Evaluation of Parametrial Spread in Endometrial Carcinoma

Yoh Watanabe, Takao Satou, Hidekatsu Nakai et al. · Obstetrics and Gynecology · 2010 · 43 citations

Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer

Yoh Watanabe, Tomomaro Etoh, Eiji Koike et al. · International Journal of Clinical Oncology · 2010 · 23 citations

Medicine, Metronomic Therapy, Gynecology +6

Adenocarcinoma of the lower female genital tract in patients with Herlyn-Werner-Wunderlich syndrome

Yoh Watanabe, Tomomaro Etoh, Hidekatsu Nakai · American Journal of Obstetrics and Gynecology · 2012 · 21 citations

Surgical Pathology, Histopathology, Gynecology +3

Phase II study of single-agent gemcitabine in heavily pretreated Japanese patients with recurrent ovarian cancer

Yoh Watanabe, Eiji Koike, Hidekatsu Nakai et al. · International Journal of Clinical Oncology · 2008 · 13 citations

Oncology, Medicine, Single-agent Gemcitabine +9